Proteasome inhibitors decrease paclitaxel-induced cell death in nasopharyngeal carcinoma with the accumulation of CDK1/cyclin B1

Southeast Asia is a region with high incidence of nasopharyngeal carcinoma (NPC). Paclitaxel is the mainstay for the treatment of advanced nasopharyngeal cancer. The present study investigated the effect of proteasome inhibitors on the therapeutic effect of paclitaxel and its related mechanism. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Ling, Pan, Xi, Hu, Jinyue, Zeng, Hong, Liu, Xueting, Jiang, Manli, Jiang, Binyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416144/
https://www.ncbi.nlm.nih.gov/pubmed/34435645
http://dx.doi.org/10.3892/ijmm.2021.5026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416144/
https://www.ncbi.nlm.nih.gov/pubmed/34435645
http://dx.doi.org/10.3892/ijmm.2021.5026

Ejemplares similares